It, therefore, seems that when VEGF produced by podocytes is blocked by bevacizumab, endothelial cells are damaged by lack of the VEGF survival signal, causing thrombotic microangiopathy.

Two independent studies show that ephrin-B2 controls the internalization and signaling of two types of vascular endothelial growth factor (VEGF) receptors—thereby regulating VEGF-induced ...